Biden Admin Looks To Take Over Expensive Drug Patents
The Biden administration announced a framework Thursday morning that proposes including prices as a factor when deciding if the public can easily obtain a taxpayer-funded drug and allowing government agencies to...To view the full article, register now.
Already a subscriber? Click here to view full article